Description
The global protein expression services market estimated to be valued US$ 532.8 Mn in 2021 and poised to grow at significant CAGR over 2021-2027. This report gives comprehensive outlook on protein expression services across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. This report gives historical, current, and future market sizes (US$ Mn) on the basis of proteins, and region. This report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, this report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global protein expression services market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global protein expression services market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global protein expression services products. Global market is surging owing to strategic collaborations and acquisitions and mergers among the market players to strengthen their position in the market. For instance, in In August 2018, Avista Healthcare Public Acquisition has announced that they have entered into a definitive merger agreement with Organogenesis Inc., under which Organogenesis will become a wholly owned subsidiary of AHPHAC.